These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33980265)

  • 41. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
    Chen G; Wang M; Liu X
    Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2.
    Wu H; Yu Z; Chen Q; Li D; Chen W
    J BUON; 2020; 25(2):1013-1021. PubMed ID: 32521900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.
    Gao S; Wang J; Tian S; Luo J
    Int J Oncol; 2019 Jun; 54(6):1921-1932. PubMed ID: 31081054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
    Tan Y; Chen L; Li S; Hao H; Zhang D
    Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
    Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
    BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
    Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
    Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.
    Wang M; Wang L; Ren T; Xu L; Wen Z
    Cancer Biol Ther; 2013 Feb; 14(2):155-63. PubMed ID: 23192273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR.
    He M; Yan G; Wang Y; Gong R; Lei H; Yu S; He X; Li G; Du W; Ma T; Gao M; Yu M; Liu S; Xu Z; Idiiatullina E; Zagidullin N; Pavlov V; Cai B; Yuan Y; Yang L
    J Cell Mol Med; 2021 Jun; 25(11):4962-4973. PubMed ID: 33960631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
    Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
    Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
    Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
    Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
    Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
    Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.
    Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W
    J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
    Pan W; Wang H; Jianwei R; Ye Z
    Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.